miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.
about
Genome-wide analysis of microRNA and mRNA expression signatures in cancerSmall molecule compounds targeting miRNAs for cancer therapyA Systematic Evaluation of Feature Selection and Classification Algorithms Using Simulated and Real miRNA Sequencing Data.Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview.Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.Surprisal analysis characterizes the free energy time course of cancer cells undergoing epithelial-to-mesenchymal transitionBioinspired nanocomplex for spatiotemporal imaging of sequential mRNA expression in differentiating neural stem cells.MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?MicroRNA-derived fragment length polymorphism assay.Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.Computational surprisal analysis speeds-up genomic characterization of cancer processes.An integrated network of microRNA and gene expression in ovarian cancer.Elucidating MicroRNA Regulatory Networks Using Transcriptional, Post-transcriptional, and Histone Modification Measurements.Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer.A Thermodynamic-Based Interpretation of Protein Expression Heterogeneity in Different Glioblastoma Multiforme Tumors Identifies Tumor-Specific Unbalanced Processes.Cancer network activity associated with therapeutic response and synergism.Thermodynamically inspired classifier for molecular phenotypes of health and diseaseRole of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation.miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.Statistical thermodynamics of transcription profiles in normal development and tumorigeneses in cohorts of patients.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancermiR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer.Comparative aspects of MicroRNA Expression in Canine and Human Cancer.Inhibition of KPNA4 attenuates prostate cancer metastasis.Surprisal analysis of genome-wide transcript profiling identifies differentially expressed genes and pathways associated with four growth conditions in the microalga Chlamydomonas.
P2860
Q26795603-4A097453-0992-41C8-A7C9-49FB704CE5A6Q26829982-2B5DD767-EB42-4106-B6C6-8E08841B863EQ31012249-E278AC84-76C1-49E7-914A-165E777CD876Q33737290-62A122E8-2A47-4EB3-81A0-3CA88FE0B074Q34032623-0FD1F6A6-2CF7-425A-892E-E2CB346B1DF4Q34435169-E0E2D10E-5463-4DEC-8210-CBD363C35C84Q34783003-A91CA96B-8243-4820-8A82-894108EBA84FQ35140553-2710A94B-4797-47CE-8F7F-34A8E44372BDQ35198177-FEED14ED-A4B7-46AA-A8C3-29C9555F1F12Q35342948-86DB5ECA-DE60-4C9B-8E5C-B1AD71AE9FA2Q35431478-A276FDE3-2D55-44A4-B0E7-8022CB27072FQ35477129-84C2EAF2-F614-45A6-A988-0AAEA1FF4A6FQ36798313-EB2E72BF-D8B6-4206-88DC-6D698DCB7C71Q36845839-05337F2F-82EE-446C-A5FF-369D2F5AAB2FQ37077653-087FB7D1-9783-4308-BF78-F3CBCAE54EC5Q37199267-835F4419-7CA3-40E6-93E1-33EB8B36B701Q37352952-266AB258-D697-4677-9BE1-7D6064081FBAQ38258014-E83769BF-8BA5-4491-B11C-94A5F0812BABQ38539670-BD499B94-61ED-4AA8-A622-75E48EAA15EDQ38924922-8D785623-7E85-40FB-AFB9-633FF2A88898Q39017073-9617AB48-F4DA-43BF-A3B1-299992A000AEQ40625653-F43528E2-D92D-4587-9FD7-196175D3968CQ41552614-93A2C6BE-D1F8-4767-8542-6D4FF2978C96Q43869522-C83AA430-5C03-42DE-B81C-8ADDE5545571Q43878782-0C9DC600-7490-486B-BB8A-01880B952DBFQ46304395-BE0286DF-E6C7-429C-AB0B-8691E8B9C784Q46797418-891F4879-07E0-4E0F-9405-51863924714DQ52583065-2D122B3F-8C61-495E-99D7-3496FF0AEA9E
P2860
miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@en
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@nl
type
label
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@en
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@nl
prefLabel
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@en
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@nl
P2860
P356
P1476
miRNA and mRNA cancer signatur ...... in large cohorts of patients.
@en
P2093
R D Levine
Sohila Zadran
P2860
P304
19160-19165
P356
10.1073/PNAS.1316991110
P407
P577
2013-10-07T00:00:00Z